BioSpace News Archive

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, July 29, 2021.

BioCryst Pharmaceuticals, Inc. announced the designs for REDEEM-1 and REDEEM-2, two upcoming pivotal trials with its oral Factor D inhibitor, BCX9930, in patients with paroxysmal nocturnal hemoglobinuria.

Compugen Ltd. announced that the first patient has been dosed in its Phase 1 clinical study evaluating the dual combination of COM902, the Company’s potential best-in-class, high-affinity anti-TIGIT antibody and COM701, Compugen’s first-in-class anti-PVRIG antibody in patients with advanced malignancies who have exhausted all available standard therapies.

IMV Inc. announced the pricing of its previously-announced underwritten public offering of 14,285,714 units at a price to the public of US$1.75 per Unit, for aggregate gross proceeds to the Corporation of approximately US$25 million, before deducting underwriting commissions and Offering expenses and excluding any proceeds the Corporation may receive from the exercise of the underlying warrants.

Plus Therapeutics, Inc. announced that the Company will report second quarter 2021 financial results on Thursday, July 22, 2021, after market close.

Prometheus Biosciences, Inc. today announced it will host its virtual R&D Day for analysts and investors at 9:00 a.m. ET on Wednesday, July 28, 2021.

ICU Medical, Inc. today announced the time of its second quarter 2021 earnings release and conference call. The Company will release its second quarter 2021 results on Wednesday, August 4, 2021 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call.

Generate Life Sciences (Generate) today announced the establishment of its Good Manufacturing Practice (GMP) facility in La Jolla, Calif. which will enable end-to-end manufacturing for newborn stem cell biologics.

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Armin Schon, Ph.D., has been appointed chief commercial officer, effective immediately.

Thermo Fisher Scientific, the world leader in serving science, today announced the Thermo Scientific Phenom Pharos G2 Desktop Field Emission Gun - Scanning Electron Microscope (FEG-SEM) designed to increase access to advanced nanomaterial research capabilities.